Biohaven Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	96.05	110.31	89.24	62.77	130.86	37.41
Research & Development	391.43	598.05	795.87	373.28	437.07	181.49
Operating Expenses	487.47	708.37	885.11	436.05	567.93	218.9
Operating Income	-487.47	-708.37	-885.11	-436.05	-567.93	-218.9
Earnings From Equity Investments	-	-	-	-	-	5.26
Other Non Operating Income (Expenses)	-20.06	-6.59	18.09	8.81	-5.12	1.21
EBT Excluding Unusual Items	-507.53	-714.95	-867.02	-427.24	-573.05	-212.43
Merger & Restructuring Charges	-0.01	-0.01	-	-	-	-
Gain (Loss) on Sale of Investments	2.82	14.59	21.33	17.69	3.21	-
Other Unusual Items	-37	-37	-	-	-	-
Pretax Income	-541.73	-737.38	-845.69	-409.55	-569.84	-212.43
Income Tax Expense	0.95	1.44	0.74	-1.38	0.44	1.37
Net Income	-542.68	-738.82	-846.42	-408.17	-570.28	-213.8
Net Income to Common	-542.68	-738.82	-846.42	-408.17	-570.28	-213.8
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	142	108	91	71	45	39
Shares Outstanding (Diluted)	142	108	91	71	45	39
Shares Change	38.52%	17.96%	28.14%	59.14%	13.63%	-
EPS (Basic)	-3.81	-6.86	-9.28	-5.73	-12.75	-5.43
EPS (Diluted)	-3.81	-6.86	-9.28	-5.73	-12.75	-5.43
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-473.17	-610.15	-586.5	-334.77	-303.76	-146.78
Free Cash Flow Per Share	-3.32	-5.67	-6.43	-4.70	-6.79	-3.73
EBITDA	-478.05	-698.45	-877.26	-429.14	-566.55	-217.51
D&A For EBITDA	9.42	9.92	7.86	6.91	1.39	1.39
EBIT	-487.47	-708.37	-885.11	-436.05	-567.93	-218.9

SEC Filings: 10-K · 10-Q